Abstract
Stephen Hoffman and colleagues from the Naval Medical Research Center and J. Craig Venter from TIGR propose a strategy for applying the wealth of information that will come from sequencing the entire genome of Plasmodium falciparum (the parasite that causes the fatal form of malaria) to the development of a malaria vaccine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hoffman, S.L. Malaria vaccine development: A multi-immune response approach. (American Society for Microbiology, Washington, D.C., 1996).
Hall, R. et al. Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature 311, 379– 382 (1984).
Butler, D. Funding assured for international malaria sequencing project. Nature 388, 701–701 (1997).
Hoffman, S.L. et al. Funding for malaria genome sequencing. Nature 387, 647–647 (1997).
Gardner, M.J. et al. Chromosome 2 sequence of the human malaria parasite P. falciparum. Science 282, 1126– 1132 (1998).
Wang, R. et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476–480 (1998).
Doolan, D.L. & Hoffman, S.L. Pre-erythrocytic stage immune effector mechanisms in Plasmodium spp. infections. Phil. Trans. R. Soc. Lond. Biol. 352, 1361– 1367 (1997).
Christophers, S.R. The mechanism of immunity against malaria in communities living under hyper-endemic conditions. Indian J. Med. Res. 12, 273– 294 (1924).
Sidney, J., Grey, H.M., Kubo, R.T. & Sette, A. Practical, biochemical and evolutionary implications of the discovery of HLA Class I supertypes. Immunol. Today 17, 261– 266 (1996).
Doolan, D.L. et al. Degenerate cytotoxic T-cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7, 97–112 (1997).
Doolan, D.L. & Hoffman, S.L. Multi-gene vaccination against malaria: A multistage, multi-immune response approach. Parasitol. Today 13, 171–178 (1997).
Barry, M.A., Lai, W.C. & Johnston, S.A. Protection against mycoplasma infection using expression-library immunization. Nature 377, 632– 635 (1995).
Acknowledgements
The authors thank D. Doolan for critical reading of the manuscript. The work described was funded by Naval Medical Research and Development Command Work Units 61102AA0101BFX and 611102A0101BCX. The opinions expressed are those of the authors and do not reflect the official policy of the Department of the Navy, Department of Defense, or the U.S. government.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffman, S., Rogers, W., Carucci, D. et al. From genomics to vaccines: Malaria as a model system . Nat Med 4, 1351–1353 (1998). https://doi.org/10.1038/3934
Issue date:
DOI: https://doi.org/10.1038/3934
This article is cited by
-
Identification of Proteins in Streptococcus pneumoniae by Reverse Vaccinology and Genetic Diversity of These Proteins in Clinical Isolates
Applied Biochemistry and Biotechnology (2015)
-
A protective paradox
Nature (2006)
-
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites
Nature (2006)
-
How can immunology contribute to the control of tuberculosis?
Nature Reviews Immunology (2001)
-
Is the development of a new tuberculosis vaccine possible?
Nature Medicine (2000)
